Basel Medical Group Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| XTX TOPCO LTD | 05/15/2026 | 25.76 K | $15.66 K | -15.36% | 0.14% |
| 05/07/2026 | 15.00 K | $8.85 K | 100.00% | 0.08% | |
| UBS GROUP AG | 05/05/2026 | 13.06 K | $7.70 K | 61.40% | 0.07% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 04/21/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| BELL INVESTMENT ADVISORS, INC | 04/17/2026 | 0 | $0 | -100.00% | 0.00% |
Basel Medical Group Ltd. institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Basel Medical Group Ltd.. The most heavily invested institutionals were:
XTX Topco Ltd: 25,756
UBS Group AG: 13,056
Ground Swell Capital, LLC: 0
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 0
JANE STREET GROUP, LLC: 0
Bell Investment Advisors, Inc: 0
0.29% of Basel Medical Group Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 38.81 K shares in the last 24 months. This purchase volume represents approximately $22.51 K in transactions.